Adage Capital Partners Gp, L.L.C. Cidara Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $1.34 Million - $2.15 Million	-356,005 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.0 - $8.15 $1.42 Million - $2.9 Million	356,005 New	356,005 $1.42 Million

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.